AUPH
Aurinia Pharmaceuticals Inc.
Pharmaceutical PreparationsNasdaqLarge accelerated filer
Total Trades
51
Buys
7
Sells
21
Largest Trade
N/A
Insiders
19
Institutional Funds
210
Inst. Value
$1M+
Activist Filings
15
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| TANG KEVIN | Director | BUY | $1M+ | 900K | $14.10 | Mar 3, 2026 |
| Bailey Jeffrey Allen | Director | EXERCISE | N/A | 18K | — | Nov 13, 2024 |
| Bailey Jeffrey Allen | Director | SELL | $15K–$50K | 5K | $8.43 | Nov 13, 2024 |
| Smith Karen L. | Director | SELL | $15K–$50K | 5K | $8.43 | Nov 13, 2024 |
| Smith Karen L. | Director | EXERCISE | N/A | 18K | — | Nov 13, 2024 |
| Knappertz Volker | EVP | SELL | $15K–$50K | 5K | $6.10 | Feb 29, 2024 |
| Knappertz Volker | EVP | SELL | $100K–$500K | 25K | $5.48 | Feb 22, 2024 |
| Habig Scott Michael | Chief Commercial O… | SELL | $50K–$100K | 16K | $5.48 | Feb 22, 2024 |
| Habig Scott Michael | Chief Commercial O… | GRANT | N/A | 196K | — | Feb 22, 2024 |
| Jayne David R.W. | Director | GRANT | N/A | 9K | — | May 23, 2023 |
| Jayne David R.W. | Director | EXERCISE | N/A | 9K | — | May 23, 2023 |
| Jayne David R.W. | Director | SELL | $50K–$100K | 9K | $11.26 | May 23, 2023 |
| Hagan Joseph P | Director | EXERCISE | N/A | 9K | — | May 23, 2023 |
| Hagan Joseph P | Director | SELL | $1K–$15K | 272 | $10.58 | May 23, 2023 |
| Billen Daniel | Director | SELL | $50K–$100K | 5K | $11.26 | May 23, 2023 |
| Billen Daniel | Director | GRANT | N/A | 9K | — | May 23, 2023 |
| Billen Daniel | Director | EXERCISE | N/A | 9K | — | May 23, 2023 |
| MacKay-Dunn R. Hector | Director | GRANT | N/A | 9K | — | May 23, 2023 |
| MacKay-Dunn R. Hector | Director | EXERCISE | N/A | 9K | — | May 23, 2023 |
| MacKay-Dunn R. Hector | Director | SELL | $50K–$100K | 5K | $11.26 | May 23, 2023 |
| Leversage Jill | Director | GRANT | N/A | 9K | — | May 23, 2023 |
| Leversage Jill | Director | SELL | $50K–$100K | 5K | $11.26 | May 23, 2023 |
| Leversage Jill | Director | EXERCISE | N/A | 9K | — | May 23, 2023 |
| MILNE GEORGE M JR | Director | BUY | $100K–$500K | 20K | $8.91 | Mar 6, 2023 |
| Miller Joseph M | CFO | SELL | $100K–$500K | 11K | $8.94 | Mar 6, 2023 |
| Miller Joseph M | CFO | GRANT | N/A | 229K | — | Mar 6, 2023 |
| Robertson Stephen P. | EVP, General Counsel | SELL | $100K–$500K | 19K | $8.94 | Mar 6, 2023 |
| Robertson Stephen P. | EVP, General Counsel | GRANT | N/A | 205K | — | Mar 6, 2023 |
| Greenleaf Peter | CEO | SELL | $100K–$500K | 33K | $8.94 | Mar 6, 2023 |
| Greenleaf Peter | CEO | GRANT | N/A | 667K | — | Mar 6, 2023 |
| Donley Matthew Maxwell | Ex VP | BUY | $15K–$50K | 10K | $4.66 | Nov 23, 2022 |
| Habig Scott Michael | Chief Commercial O… | BUY | $15K–$50K | 5K | $5.01 | Nov 14, 2022 |
| Martin Michael Robert | Chief Business Off… | BUY | $100K–$500K | 30K | $5.16 | Nov 9, 2022 |
| MacKay-Dunn R. Hector | Director | BUY | $50K–$100K | 5K | $11.00 | Mar 11, 2022 |
| MILNE GEORGE M JR | Director | BUY | $50K–$100K | 5K | $10.82 | Mar 8, 2022 |
| Martin Michael Robert | Chief Business Off… | GRANT | N/A | 9K | — | Mar 4, 2022 |
| Martin Michael Robert | Chief Business Off… | SELL | $50K–$100K | 5K | $12.01 | Mar 4, 2022 |
| Donley Matthew Maxwell | Ex VP | GRANT | N/A | 9K | — | Mar 4, 2022 |
| Donley Matthew Maxwell | Ex VP | SELL | $15K–$50K | 3K | $12.01 | Mar 4, 2022 |
| Miller Joseph M | CFO | GRANT | N/A | 9K | — | Mar 4, 2022 |
| Miller Joseph M | CFO | SELL | $15K–$50K | 3K | $12.01 | Mar 4, 2022 |
| Colao Massimilano | Chief Commercial O… | SELL | $15K–$50K | 3K | $12.01 | Mar 4, 2022 |
| Colao Massimilano | Chief Commercial O… | GRANT | N/A | 9K | — | Mar 4, 2022 |
| Greenleaf Peter | CEO | SELL | $100K–$500K | 9K | $12.01 | Mar 4, 2022 |
| Greenleaf Peter | CEO | GRANT | N/A | 28K | — | Mar 4, 2022 |
| Solomons Neil | Chief Medical Offi… | SELL | $50K–$100K | 5K | $12.01 | Mar 4, 2022 |
| Solomons Neil | Chief Medical Offi… | GRANT | N/A | 9K | — | Mar 4, 2022 |
| Huizinga Robert Bindert | EVP of Research | SELL | $50K–$100K | 5K | $12.01 | Mar 4, 2022 |
| Huizinga Robert Bindert | EVP of Research | GRANT | N/A | 9K | — | Mar 4, 2022 |
| Hagan Joseph P | Director | SELL | $500K+ | 40K | $22.59 | Jan 4, 2022 |
🔓Seeing ranges? Sign in for exact trade values — free forever
Institutional Ownership
13F filings as of Dec 31, 2025 · 210 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 11.3M | $1M+ | SH |
| NEA Management Company, LLC | 4.0M | $1M+ | SH |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 3.4M | $1M+ | SH |
| STATE STREET CORP | 2.5M | $1M+ | SH |
| RENAISSANCE TECHNOLOGIES LLC | 1.6M | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 1.4M | $1M+ | SH |
| VANGUARD GROUP INC | 1.2M | $1M+ | SH |
| NOMURA HOLDINGS INC | 1.2M | $1M+ | SH |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1.1M | $1M+ | SH |
| Man Group plc | 849K | $1M+ | SH |
| GOLDMAN SACHS GROUP INC | 769K | $1M+ | SH |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 739K | $1M+ | SH |
| LSV ASSET MANAGEMENT | 657K | $1M+ | SH |
| BNP PARIBAS FINANCIAL MARKETS | 626K | $1M+ | SH |
| MORGAN STANLEY | 540K | $1M+ | SH |
| Squarepoint Ops LLC | 444K | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 432K | $1M+ | SH |
| AMERICAN CENTURY COMPANIES INC | 403K | $1M+ | SH |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | 387K | $1M+ | SH |
| Connor, Clark & Lunn Investment Management Ltd. | 384K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13D/A · Mar 3, 2026
9.2%
12.2M shares
SC 13D/A · Aug 14, 2025
4.1%
5.4M shares
SC 13D/A · Mar 4, 2025
7.3%
10.0M shares
SC 13G/A · Feb 14, 2025
4.5%
6.4M shares
SC 13G/A · Nov 14, 2024
5.7%
8.2M shares
SC 13D · Sep 12, 2024
5.1%
7.2M shares
SC 13D/A · Mar 20, 2024
4.4%
6.4M shares
SC 13G · Feb 14, 2024
6.6%
9.5M shares
SC 13D/A · May 10, 2023
4.2%
6.1M shares
SC 13G/A · Feb 14, 2023
0.2%
324K shares
SC 13D/A · Jan 20, 2023
4.3%
6.1M shares
SC 13D/A · Jan 6, 2023
4.3%
6.1M shares
SC 13G · Oct 28, 2022
5.5%
7.8M shares
SC 13D/A · Mar 3, 2022
4.0%
5.7M shares
SC 13G/A · Feb 14, 2022
0.0%
0 shares